China SXT Pharmaceuticals (SXTC) Short-term Investments (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Short-term Investments for 7 consecutive years, with $368.0 the latest figure, recorded in Q1 2026.

• Quarterly Short-term Investments fell 98.79% year-over-year to $368.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $368.0 (down 98.79% YoY) and the FY2026 annual result came in at $368.0, down 98.79% from the prior year.
• Short-term Investments retreated to $368.0 in Q1 2026 per SXTC's latest filing, from $31001.0 in the prior quarter.
• Over the last five years, Short-term Investments for SXTC reached as high as $45297.0 in Q1 2022 and fell as low as $368.0 in Q1 2026.
• A 4-year average of $22784.2 and a median of $30413.0 in 2025 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2025 — Short-term Investments jumped 344.5% — and 2026, when it tumbled 98.79%.
• Year by year, Short-term Investments stood at $45297.0 in 2022, then plunged by 84.9% to $6842.0 in 2024, then jumped by 353.1% to $31001.0 in 2025, then plunged by 98.81% to $368.0 in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $368.0, $31001.0, and $30413.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.